​

Labcorp Holdings (LH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LH Stock Forecast

Labcorp Holdings (LH) stock forecast, based on 35 Wall Street analysts, predicts a 12-month average price target of $328.50, with a high of $355.00 and a low of $300.00. This represents a 1.12% increase from the last price of $324.86.

$150 $200 $250 $300 $350 $400 High: $355 Avg: $328.5 Low: $300 Last Closed Price: $324.86

LH Stock Rating

Labcorp Holdings stock's rating consensus is Buy, based on 35 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 26 Buy (74.29%), 9 Hold (25.71%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 35 0 9 26 Strong Sell Sell Hold Buy Strong Buy

LH Price Target Upside V Benchmarks

TypeNameUpside
StockLabcorp Holdings1.12%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks7.15%

Price Target Trends

1M3M12M
# Anlaysts1518
Avg Price Target$355.00$334.20$320.56
Last Closing Price$324.86$324.86$324.86
Upside/Downside9.28%2.88%-1.32%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 262114-118
Aug, 262115--18
Jul, 262125--19
Jun, 263124--19
May, 262125--19
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 10, 2026Ann HynesMizuho Securities$355.00$319.1711.23%9.28%
Jul 31, 2026Morgan Stanley$338.00$308.649.51%4.04%
Jul 31, 2026Deutsche Bank$306.00$308.70-0.87%-5.81%
Jul 31, 2026Robert W. Baird$352.00$315.5311.56%8.35%
Jul 30, 2026Barclays$320.00$315.821.32%-1.50%
May 01, 2026Eric ColdwellRobert W. Baird$334.00$255.9730.48%2.81%
Apr 08, 2026Evercore ISI$300.00$274.729.20%-7.65%
Feb 24, 2026David WestenbergPiper Sandler$300.00$285.305.15%-7.65%
Feb 18, 2026Robert W. Baird$326.00$276.6717.83%0.35%
Jan 14, 2026Robert W. Baird$313.00$259.1820.77%-3.65%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 31, 2026Morgan StanleyOverweightOverweighthold
Jul 31, 2026Deutsche BankHoldHoldhold
Apr 08, 2026Evercore ISIOutperformOutperformhold
Feb 24, 2026Piper SandlerNeutralNeutralhold
Feb 17, 2026Morgan StanleyOverweightOverweighthold
Oct 28, 2025Leerink PartnersOutperformOutperformhold
Oct 17, 2025UBSBuyBuyhold
Oct 03, 2025Evercore ISIOutperformOutperformhold
Jul 25, 2025UBSBuyBuyhold
Jul 10, 2025HSBCBuyHolddowngrade

Financial Forecast

EPS Forecast

$0 $5 $10 $15 $20 $25 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$24.58$14.04$4.80$8.89$10.54----
Avg Forecast$23.84$17.07$13.54$14.52$16.04$17.65$19.56$21.53$21.67
High Forecast$23.84$17.07$13.64$14.56$16.28$18.43$21.27$21.84$21.98
Low Forecast$23.84$17.07$13.48$14.45$15.82$16.45$17.16$21.22$21.36
Surprise %3.10%-17.75%-64.55%-38.77%-34.29%----

Revenue Forecast

$12B $13B $14B $15B $16B $17B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$13.14B$11.86B$12.16B$13.01B$13.95B----
Avg Forecast$16.01B$14.94B$12.15B$12.99B$13.90B$14.58B$15.40B$16.37B$14.78B
High Forecast$16.01B$14.94B$12.16B$13.01B$14.05B$14.86B$15.48B$16.55B$14.94B
Low Forecast$16.01B$14.94B$12.14B$12.98B$13.82B$14.25B$15.32B$16.19B$14.61B
Surprise %-17.95%-20.60%0.13%0.17%0.37%----

Net Income Forecast

$0 $500M $1B $2B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$2.38B$1.28B$418.00M$746.00M$876.50M----
Avg Forecast$1.89B$1.74B$379.20M$1.22B$1.35B$1.47B$1.62B$1.81B$1.82B
High Forecast$2.26B$2.08B$455.04M$1.23B$1.37B$1.55B$1.79B$1.84B$1.85B
Low Forecast$1.51B$1.39B$303.36M$1.22B$1.33B$1.39B$1.44B$1.79B$1.80B
Surprise %25.95%-26.30%10.23%-38.93%-35.15%----

LH Forecast FAQ

Is Labcorp Holdings stock a buy?

Labcorp Holdings stock has a consensus rating of Buy, based on 35 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 26 Buy, 9 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Labcorp Holdings is a favorable investment for most analysts.

What is Labcorp Holdings's price target?

Labcorp Holdings's price target, set by 35 Wall Street analysts, averages $328.5 over the next 12 months. The price target range spans from $300 at the low end to $355 at the high end, suggesting a potential 1.12% change from the previous closing price of $324.86.

How does Labcorp Holdings stock forecast compare to its benchmarks?

Labcorp Holdings's stock forecast shows a 1.12% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the diagnostics & research stocks industry (7.15%).

What is the breakdown of analyst ratings for Labcorp Holdings over the past three months?

  • September 2026: 11.11% Strong Buy, 61.11% Buy, 22.22% Hold, 0% Sell, 5.56% Strong Sell.
  • August 2026: 11.11% Strong Buy, 61.11% Buy, 27.78% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 10.53% Strong Buy, 63.16% Buy, 26.32% Hold, 0% Sell, 0% Strong Sell.

What is Labcorp Holdings’s EPS forecast?

Labcorp Holdings's average annual EPS forecast for its fiscal year ending in December 2026 is $17.65, marking a 67.46% increase from the reported $10.54 in 2025. Estimates for the following years are $19.56 in 2027, $21.53 in 2028, and $21.67 in 2029.

What is Labcorp Holdings’s revenue forecast?

Labcorp Holdings's average annual revenue forecast for its fiscal year ending in December 2026 is $14.58B, reflecting a 4.51% increase from the reported $13.95B in 2025. The forecast for 2027 is $15.4B, followed by $16.37B for 2028, and $14.78B for 2029.

What is Labcorp Holdings’s net income forecast?

Labcorp Holdings's net income forecast for the fiscal year ending in December 2026 stands at $1.47B, representing an 67.53% increase from the reported $876.5M in 2025. Projections indicate $1.62B in 2027, $1.81B in 2028, and $1.82B in 2029.